Cat. No.: X24-11-YM009
GalNAc-L96 intermediate, B3, Purity ≥98%
Synonym: 200133-16-0; 3-[2-Benzyloxycarbonylamino-3-(2-carboxy-ethoxy)-2-(2-carboxy-ethoxymethyl)-propoxy]-propionic acid; 3,3'-[[2-[(2-Carboxyethoxy)methyl]-2-[[(phenylmethoxy)carbonyl]amino]-1,3-propanediyl]bis(oxy)]bis[propanoic acid]; 3-[3-(2-Carboxyethoxy)-2-(2-carboxyethoxymethyl)-2-(phenylmethoxycarbonylamino)propoxy]propanoic acid; Cbz-N-tris tri-acid
- MDL: MFCD28966608
- CAS Number: 200133-16-0
Product Size
1 g; 2 g; 5 g; 10 g
Properties
Description
A triantennary GalNAc ligand, GalNAc-L96, which effectively binds to ASGPR, supports the production of GalNAc-siRNA with improved hepatocyte targeting. B3 is applied for the synthesis of GalNAc-L96 for use in targeted therapy research for diseases.
Molecular Formula
C21H29NO11
Purity
≥98%, determined by HPLC.
Impurities
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects.
Identity
Conforms to structure, determined by 1H NMR.
Related Products
-
GalNAc-L96 intermediate, L1, Purity ≥98%
-
GalNAc-L96 intermediate, L2, Purity ≥98%
-
GalNAc-L96 intermediate, L3, Purity ≥98%
-
GalNAc-L96 intermediate, L4, Purity ≥98%
-
GalNAc-L96 intermediate, L5-Acid, Purity ≥98%
-
GalNAc-L96 intermediate, L5-Acid-TEA, Purity ≥98%
Quick Links